Cite
HARVARD Citation
Andreatta, K. et al. (2018). HIV-1 Proviral Sequence and Treatment Outcome of Virologically Suppressed Patients Switching to Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate. Journal of acquired immune deficiency syndromes. p. . [Online].